The databook is designed to serve as a comprehensive guide to navigating this
sector. The databook focuses on market statistics denoted in the form of
revenue and y-o-y growth and CAGR across the globe and regions. A detailed
competitive and opportunity analyses related to biotechnology instruments market will
help companies and investors design strategic landscapes.
- U.S. Biotechnology Instruments Product Outlook (Revenue, USD Million, 2018-2030)
- Analytical Instruments
- Polymerase Chain Reaction
- Spectroscopy
- Microscopy
- Chromatography
- Flow Cytometry
- Sequencing
- Microarray
- Others
- Cell Culture Instruments
- Culture Systems
- Incubators
- Cryostorage Equipment
- Biosafety Equipment
- Pipetting Instruments
- Cell Separation Instruments
- Centrifuge
- Filtration Systems
- Magnetic-activated Cell Separator Systems
- Immunoassay Instruments/Analyzers
- Clinical Chemistry Analyzers
- Others
- U.S. Biotechnology Instruments End use Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Others
Reasons to
subscribe to U.S. biotechnology instruments market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of
U.S. biotechnology instruments market databook
-
Our clientele includes a mix of biotechnology instruments market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed
overview of
country-level
data and insights on the U.S. biotechnology instruments market , including
forecasts for subscribers. This
country
databook contains high-level insights into
U.S. biotechnology instruments market from
2018 to
2030, including revenue
numbers, major trends, and company profiles.